Key result
ECMO successfully supports a pregnant woman with fulminant myocarditis to cardiac recovery and safe discharge.
Why the study?
There are no prior reports of pregnant women with fulminant myocarditis treated with Extracorporeal Membrane Oxygenation (ECMO).
Does ECMO improve survival in a pregnant woman with fulminant myocarditis?
Population
A 32-year-old pregnant woman with fulminant myocarditis
Comparison
ECMO treatment following antiviral and cardioprotective therapy with pregnancy termination
Design
Case report
Follow-up
Until hospital discharge
Authors
Loading...
Supports ECMO feasibility in pregnant fulminant myocarditis; leaves open survival benefit confirmation beyond this case.
Case Report (n=1)
No
Does ECMO improve survival in a pregnant woman with fulminant myocarditis?
ECMO can be a successful life-saving treatment for pregnant women presenting with fulminant myocarditis.
Lin et al. (2021) conducted a case report in Fulminant myocarditis (n=1). Extracorporeal Membrane Oxygenation (ECMO) was evaluated on Clinical recovery and survival. Extracorporeal membrane oxygenation successfully supported a 32-year-old pregnant woman with fulminant myocarditis, leading to marked improvement in cardiac function and safe discharge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: